1. Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients.
- Author
-
Özdemir, Zehra Narlı, İpek, Yıldız, Patır, Püsem, Ermiş, Gözde, Çiftçiler, Rafiye, Özmen, Deniz, Baysal, Mehmet, Gürsoy, Vildan, Yıldızhan, Esra, Güven, Serkan, Ercan, Tarık, Elibol, Tayfun, Mersin, Sinan, Genç, Eylem, Davulcu, Eren Arslan, Karakuş, Volkan, Erkut, Nergiz, Güneş, Gürsel, Küçükkaya, Reyhan Diz, and Eşkazan, Ahmet Emre
- Subjects
LEUKEMIA risk factors ,THROMBOEMBOLISM risk factors ,PROTEINS ,RISK assessment ,PLATELET count ,HEMOGLOBINS ,MYELOPROLIFERATIVE neoplasms ,TREATMENT effectiveness ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,AGE distribution ,MULTIVARIATE analysis ,JANUS kinases ,RESEARCH ,HYDROXYUREA ,GENETIC mutation ,THROMBOCYTOSIS ,MYELOFIBROSIS ,PROGRESSION-free survival ,DISEASE progression ,OVERALL survival ,DISEASE risk factors - Abstract
Copyright of Turkish Journal of Hematology is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF